002728.SZ
Teyi Pharmaceutical Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 8.60
−3.37%Margins
Gross margin
52.7%
EBITDA margin
18.0%
EBIT margin
9.2%
Net margin
9.0%
FCF margin
11.0%
4.1%
Return on equity
3.3%
Return on assets
3.6%
Return on invested capital
0.36x
Asset turnover
CNY 166.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026